Theresa Perrin
Self-Directed Investor & Trader, Former Hospice Nurse
SoundHound AI is the best short-squeeze opportunity in the market after blowout earnings, with short interest above 43%. Only about 600,000 shares remain available to short, borrowing costs 9.89%, and covering would take over seven days at current volume. More than 56% of trades are going through dark pools, which explains the falling price. x.com x.comÂ
SoundHound AI's growth and stock price have disconnected, and that kind of gap doesn't usually last: either growth slows or the stock catches up. It builds voice AI that lets people talk naturally to cars, restaurants and customer service systems. Revenue is up 54% year over year, yet the stock is down 35% this year and 70% below its peak, with the average analyst target nearly double the current price. x.comÂ
SoundHound AI's weekly chart shows a potential reversal, backed by a broad partner base. Automotive partners include Hyundai, Stellantis, Honda and Kia; in telecom it is the exclusive agentic AI provider for Associated Carrier Group's smaller carriers and works with Deutsche Telekom and Telefonica; technology partners include Nvidia, OpenAI, DeepSeek and Perplexity, with Salesforce tied to an Army contract. x.comÂ
SoundHound AI faces massive dilution because it is burning cash heavily with only about a year of runway and is nowhere near profitability. It trades at about 16x sales with a 41% short float, and is unlikely to trade above $20 for years without something extraordinary. x.comÂ
SoundHound AI is growing quickly in voice and agentic AI across automotive, hospitality and enterprise. Q1 2026 revenue rose 52% to $44.2M, with core vertical growth of 88% excluding acquisitions, and it holds $216M of cash with zero debt. Full-year guidance is $225M-260M, and its LivePerson acquisition unlocks a $500M combined revenue opportunity. x.comÂ
Better underwriting at Root, AI data demand at Innodata, defense breadth at Applied Aerospace & Defense, scaled voice AI at SoundHound, more organ access via TransMedics, profitable insurance at Lemonade, autonomous defense at Ondas and successful medicines at AbCellera could drive outsized growth. These eight smaller companies have a realistic path to 5x+ over 5-10 years if they execute on those opportunities. x.com x.com x.com x.com x.com x.com x.com x.comÂ
SoundHound AI's valuation prices durable scarcity in voice, the capability AI is commoditizing fastest and that hyperscalers bundle for free. Software is the wrong place to be when AI lowers barriers to entry rather than raising them. It trades at 16x sales on 52% growth, but a 41% gross margin and a negative 139% operating margin mean every dollar of growth is bought at a loss. That is a story, not a bottleneck, and not worth buying at this level. x.comÂ